Wednesday, October 7, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· March 25, 2026

Stocks Rally on US Peace Plan to End Iran War

View original at nasdaq.com
Stocks Rally on US Peace Plan to End Iran War The S&P 500 Index ($SPX) (SPY) today is up +0.62%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.67%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.75%…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • ARM will start selling its own chips for the first time and expects to generate about $15 billion annually within five years

    60% confidence
  • Crude prices could exceed the 2008 record high of close to $150 a barrel if flows through the Strait of Hormuz remain depressed through March

    60% confidence
  • It is too early to determine the response to the war, and we will not act before we have sufficient information on the size and persistence of the shock and its propagation

    60% confidence
  • Q2 home deliveries forecast of 2,250 to 2,450

    60% confidence
  • The initial shock may be smaller than in 2022, given a more benign macroeconomic backdrop

    60% confidence
  • War against Iran is disrupting 7.5% of global oil supply and the conflict will cut global oil supply by 8 million bpd this month

    60% confidence
  • Iran rejects the US ceasefire proposal and said a truce and peace talks are not viable in current conditions

    60% confidence
  • 2027 net sales forecast of $13.60 billion to $13.75 billion

    60% confidence
  • 2027 revenue forecast of $884 million to $889 million

    60% confidence
  • General Motors upgraded to outperform from peer perform with price target of $96

    60% confidence
  • More than 40 energy sites across nine countries in the Middle East have been severely or very severely damaged, potentially prolonging disruptions to global supply chains once the war in Iran ends

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com